Boston ScientificRegister for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
Boston Scientific (BSX) reported revenue of $5.44B in Q2 2026, with Cardiovascular its largest revenue segment at 67%.
Boston ScientificBoston Scientific develops medical devices used in interventional procedures across cardiovascular and MedSurg specialties, including Watchman left atrial appendage closure and FARAPULSE pulsed field ablation.
Boston Scientific (BSX) is a Health Care Equipment company. Boston Scientific develops medical devices used in interventional procedures across cardiovascular and MedSurg specialties, including Watchman left atrial appendage closure and FARAPULSE pulsed field ablation. It was founded in 1979, is headquartered in Marlborough, Massachusetts and employs about 59,000 people.
As of 2026-Q2, Boston Scientific's revenue breaks down across Cardiovascular (67%), MedSurg (33%). See the revenue-by-segment chart for the full mix.
Track Boston Scientific's quarterly and annual revenue, gross and net margins, and EPS in the interactive charts on this page. Data last updated August 26, 2026.
Sterling groups Boston Scientific in the Healthcare sector, alongside Abbott Laboratories (ABT), Baxter International (BAX), Becton Dickinson (BDX), Edwards Lifesciences (EW), GE HealthCare (GEHC) and Idexx Laboratories (IDXX).
If you are researching Boston Scientific, also look at Abbott Laboratories (ABT), Baxter International (BAX) and Becton Dickinson (BDX). You can compare all of them side by side or browse the full Healthcare sector on Sterling.
Q3 2016-Q2 2026
Q3 2016-Q2 2026